Patient Coalition Pushes For Changes To FDA's Biosimilar Educational Materials

February 14, 2018 at 11:59 PM
Updated Story Patients for Biologics Safety & Access is calling on FDA to rework portions of its newly released web page meant to educate prescribers about biosimilars, with the group suggesting changes aimed at downplaying the agency's safety assurances. The group -- which has continually sounded the alarm over potential risks of biosimilars, despite admission from the group's head that the group doesn't have concrete evidence of higher adverse events with the drugs -- wants FDA to...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.